Neurogene (NGNE) Cash from Operations (2013 - 2026)
Neurogene (NGNE) posted Cash from Operations of 26100000.0 for Q1 2026, down 49.37% on a QoQ basis from 17473000.0 in Q4 2025, and down 25.64% year-over-year from 35098485.24 in Q1 2025.
Neurogene (NGNE) Cash from Operations (2013 - 2026) Analysis & Trends
Neurogene's Cash from Operations history runs 14 years deep, the most recent figure standing at 26100000.0 for Q1 2026.
- Quarterly Cash from Operations fell 25.64% year-over-year to 26100000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 82499000.0 (down 18.32% YoY) and the FY2025 annual result came in at 77173000.0, down 9.31% from the prior year.
- Cash from Operations was 26100000.0 for Q1 2026 at Neurogene, down from 17473000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 9289000.0 in Q3 2022 and bottomed at 26100000.0 in Q1 2026.
- A 5-year average of 16358705.88 and a median of 16972000.0 in 2023 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2023 — Cash from Operations rose 17.26% — and 2024, when it plunged 70.07%.
- Neurogene's Cash from Operations stood at 18126000.0 in 2022, then gained by 6.37% to 16972000.0 in 2023, then fell by 3.09% to 17496000.0 in 2024, then climbed by 0.13% to 17473000.0 in 2025, then slumped by 49.37% to 26100000.0 in 2026.
- Business Quant data shows NGNE's Cash from Operations at 26100000.0 in Q1 2026, 17473000.0 in Q4 2025, and 19500000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Neurogene | 17.50 Mn | 17.50 Mn | - | -26.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.10 Mn |
| Mar 31, 2026 | -26.10 Mn |
| Dec 31, 2025 | -17.47 Mn |
| Dec 31, 2025 | -17.47 Mn |
| Sep 30, 2025 | -19.50 Mn |
| Sep 30, 2025 | -19.50 Mn |
| Jun 30, 2025 | -19.43 Mn |
| Jun 30, 2025 | -19.43 Mn |
| Mar 31, 2025 | -20.77 Mn |
| Mar 31, 2025 | -20.77 Mn |
| Dec 31, 2024 | -17.50 Mn |
| Dec 31, 2024 | -17.50 Mn |
| Sep 30, 2024 | -15.56 Mn |
| Sep 30, 2024 | -15.56 Mn |
| Jun 30, 2024 | -15.89 Mn |
| Jun 30, 2024 | -15.89 Mn |
| Mar 31, 2024 | -21.65 Mn |
| Mar 31, 2024 | -21.65 Mn |
| Dec 31, 2023 | -16.97 Mn |
| Dec 31, 2023 | -16.97 Mn |